CLINICAL_TRIALS
trial_result
· 2015-11-17
Clinical Trial Update: Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 trial comparing two titration algorithms for once-daily NN1250 in insulin-naive adults with type 2 diabetes measured efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-11-17